(R)-1-((R)-1-((R)-2-((2R,3R)-2-((S)-2-((R)-2-((R)-1-benzoylpyrrolidin-2-yl)-1-hydroxyethyl)-4-methylpentanamido)-3-methylpentanamido)-3-methylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide

ID: ALA3237154

Chembl Id: CHEMBL3237154

PubChem CID: 90671278

Max Phase: Preclinical

Molecular Formula: C40H62N6O7

Molecular Weight: 738.97

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@H](C)[C@@H](NC(=O)[C@@H](CC(C)C)[C@H](O)C[C@H]1CCCN1C(=O)c1ccccc1)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(N)=O)C(C)C

Standard InChI:  InChI=1S/C40H62N6O7/c1-7-26(6)34(37(50)42-33(25(4)5)40(53)46-21-13-18-31(46)39(52)45-20-12-17-30(45)35(41)48)43-36(49)29(22-24(2)3)32(47)23-28-16-11-19-44(28)38(51)27-14-9-8-10-15-27/h8-10,14-15,24-26,28-34,47H,7,11-13,16-23H2,1-6H3,(H2,41,48)(H,42,50)(H,43,49)/t26-,28-,29+,30-,31-,32-,33-,34-/m1/s1

Standard InChI Key:  CNLBRORFOJBNAW-DOJILBAISA-N

Associated Targets(non-human)

prt Protease (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 738.97Molecular Weight (Monoisotopic): 738.4680AlogP: 2.84#Rotatable Bonds: 16
Polar Surface Area: 182.45Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.26CX Basic pKa: CX LogP: 2.41CX LogD: 2.41
Aromatic Rings: 1Heavy Atoms: 53QED Weighted: 0.20Np Likeness Score: -0.22

References

1. Awahara C, Tatsumi T, Furuta S, Shinjoh G, Konno H, Nosaka K, Kobayashi K, Hattori Y, Akaji K..  (2014)  Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor.,  22  (8): [PMID:24680060] [10.1016/j.bmc.2014.02.050]

Source